Mouse monoclonal antibody raised against native human HLA-DRB1.
Specificity
This monoclonal antibody reacts with the beta chain of HLA-DRB1 antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B cell lymphoma.
Cross-Reactivity
Human
Immunogen
Activated human peripheral blood mononuclear cells.
HLA-DRB1
Reactivity: Human
WB, ELISA, IHC
Host: Rabbit
Polyclonal
unconjugated
Application Notes
Flow Cytometry (0.5-1 μg/106 cells in 0.1 mL) Immunofluorescence (0.5-1 μg/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.25-0.5 μg/mL) Western Blot (0.5-1 μg/mL) The optimal working dilution should be d
Restrictions
For Research Use only
Format
Liquid
Buffer
In 10 mM PBS.
Storage
-20 °C,-80 °C
Storage Comment
Store at -20 to -80°C. Aliquot to avoid repeated freezing and thawing.
Target
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))